ACE2 expresses in lung, intestinal and kidney tissues, and thus mediates relative symptoms of COVID‐19 patients, including cough, shortness of breath, fever, fatigue, and gastrointestinal symptoms such as nausea, vomiting, and diarrhea (Mehta et al., 2020). Here, ACE2 is linked to COVID-19.